Methods for treating multiple sclerosis using antisense oligonucleotides
US11891606B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 15, 2018 |
| Grant date | Feb 6, 2024 |
| Priority date | — |
| Expiry date | Aug 6, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a patient suffering from multiple sclerosis, including progressive forms of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE I to the patient, thereby treating the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.